Home › Acute Lymphoblastic Leukemia › North Carolina › Winston-Salem
Acute Lymphoblastic Leukemia clinical trials in Winston-Salem, NC
4 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Wake Forest University Health Sciences, Winston-Salem
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Wake Forest University Health Sciences, Winston-Salem
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
RecruitingObservational study
- Wake Forest Baptist Health, Winston-Salem
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Atrium Wake Forest Baptist Medical Center, Winston-Salem
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY23 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL20 studies
- Atlanta, GA19 studies
- Memphis, TN16 studies
- Washington, DC16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Mountain View, CA13 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.